| Language of instruction : English |
| | | Exam contract: not possible |
|
Sequentiality
|
| |
|
No sequentiality
|
There is no data for this choice.
Change the language, year or choose another item in the dropdown list if it is available.
| Degree programme | | Study hours | Credits | P4 SBU | P4 SP | 2nd Chance Exam1 | Tolerance2 | Final grade3 | |
 | 1st year Master of Biomedical Sciences - Environmental Health Sciences | Compulsory | 81 | 3,0 | 81 | 3,0 | Yes | Yes | Numerical |  |
|
| | | Learning outcomes |
- EC
| 1. A graduate of the Master of Biomedical Sciences has a thorough knowledge of the molecular and cellular processes of the healthy and diseased organism and has insight in different methods for prevention, diagnosis and therapy of diseases. | - EC
| 2. A graduate of the Master of Biomedical Sciences can independently and critically perform a literature search. | - EC
| 3. A graduate of the Master of Biomedical Sciences can draw up a new research hypothesis based on his or her own findings or based on the findings of others, and work out a research proposal for this. | - EC
| 4. A graduate of the Master of Biomedical Sciences has knowledge of state-of-the-art techniques within biomedical research and is able to apply these techniques, taking into account the applicable quality standards. | - EC
| 7. A graduate of the Master of Biomedical Sciences takes a critical attitude towards one's own research and that of others. | - EC
| 12. A graduate of the Master of Biomedical Sciences has an attitude for lifelong learning and for constantly adjusting one's own professional thinking and acting. |
|
| | EC = learning outcomes DC = partial outcomes BC = evaluation criteria |
|
|
Course content:
- Introduction to “Drug delivery, Pharmacology, and Toxicology”
- PART 1: From basic to controlled drug delivery
- Pharmacokinetics of drugs
- Drug delivery systems: from basic to controlled
- Toxicity tests
- PART 2: Advanced drug delivery
- Targeting strategies and its clinical applications
- Barriers to overcome
- Toxicity of ‘new emerging compounds'
- PART 3: Preclinical Validation
- Preclinical validation using case studies
Learning goals:
- The student has insight in the pharmacokinetics of drugs
- The student can explain different drug delivery systems typically used for drug delivery, including controlled release
- The student can explain active and passive targeting drug delivery and has insight in its potential applications
- The student has insight in (particle) toxicity of drug delivery systems and how to take this into account in validation studies
- The student has insight in the trajectory of validation studies and can relate the interplay between research and clinical phases (MHD/KBW/Elective course)
|
|
|
|
|
|
|
|
|
Assignment ✔
|
|
|
|
Lecture ✔
|
|
|
|
|
|
|
|
Discussion/debate ✔
|
|
|
|
Group work ✔
|
|
|
|
Journal club ✔
|
|
|
|
Presentation ✔
|
|
|
|
Report ✔
|
|
|
|
Quarter 4 (3,00sp)
| Evaluation method | |
|
| Written evaluation during teaching period | 12 % |
|
| Transfer of partial marks within the academic year | ✔ |
|
|
|
|
|
|
| Oral evaluation during teaching period | 13 % |
|
| Transfer of partial marks within the academic year | ✔ |
|
|
|
|
| Other | Discussion/Interaction and moderator skills during presentations |
|
|
|
|
|
|
| Evaluation conditions (participation and/or pass) | ✔ |
|
| Conditions | Participation during assignments is compulsory |
|
|
|
| Consequences | You cannot be evaluated on your discussion/interaction skills or presentation/moderator skills during the assignment |
|
|
|
Second examination period
| Evaluation second examination opportunity different from first examination opprt | |
|
|
|
| Prerequisites |
| |
- The student should know the basic principles in pharmacology, toxicology, molecular genetics, cell pathology
- He/she is able to read scientific papers/course material in English
|
|
|
| Compulsory textbooks (bookshop) |
| |
[],[],[],[],[],[All lecture materials will be available on blackboard.] |
|
|
|
|
|
| 1st year Master of Biomedical Sciences - Molecular Mechanisms in Health and Disease | Compulsory | 108 | 4,0 | 108 | 4,0 | Yes | Yes | Numerical | |
|
| | | Learning outcomes |
- EC
| 1. A graduate of the Master of Biomedical Sciences has a thorough knowledge of the molecular and cellular processes of the healthy and diseased organism and has insight in different methods for prevention, diagnosis and therapy of diseases. | - EC
| 2. A graduate of the Master of Biomedical Sciences can independently and critically perform a literature search. | - EC
| 4. A graduate of the Master of Biomedical Sciences has knowledge of state-of-the-art techniques within biomedical research and is able to apply these techniques, taking into account the applicable quality standards. | - EC
| 7. A graduate of the Master of Biomedical Sciences takes a critical attitude towards one's own research and that of others. | - EC
| 10. A graduate of the Master of Biomedical Sciences knows the potential for valorization of biomedical research and can translate own research into translational research. | - EC
| 12. A graduate of the Master of Biomedical Sciences has an attitude for lifelong learning and for constantly adjusting one's own professional thinking and acting. |
|
| | EC = learning outcomes DC = partial outcomes BC = evaluation criteria |
|
|
Course content:
- Introduction to “Drug delivery, Pharmacology, and Toxicology”
- PART 1: From basic to controlled drug delivery
- Pharmacokinetics of drugs
- Drug delivery systems: from basic to controlled
- Toxicity tests
- PART 2: Advanced drug delivery
- Targeting strategies and its clinical applications
- Barriers to overcome
- Toxicity of ‘new emerging compounds'
- PART 3: Preclinical Validation
- Preclinical validation using case studies
Learning goals:
- The student has insight in the pharmacokinetics of drugs
- The student can explain different drug delivery systems typically used for drug delivery, including controlled release
- The student can explain active and passive targeting drug delivery and has insight in its potential applications
- The student has insight in (particle) toxicity of drug delivery systems and how to take this into account in validation studies
- The student has insight in the trajectory of validation studies and can relate the interplay between research and clinical phases (MHD/KBW/Elective course)
|
|
|
|
|
|
|
|
|
Assignment ✔
|
|
|
|
Lecture ✔
|
|
|
|
|
|
|
|
Discussion/debate ✔
|
|
|
|
Group work ✔
|
|
|
|
Journal club ✔
|
|
|
|
Presentation ✔
|
|
|
|
Report ✔
|
|
|
|
Quarter 4 (4,00sp)
| Evaluation method | |
|
| Written evaluation during teaching period | 22 % |
|
| Transfer of partial marks within the academic year | ✔ |
|
|
|
|
|
|
|
| Oral evaluation during teaching period | 13 % |
|
| Transfer of partial marks within the academic year | ✔ |
|
|
|
|
| Other | Discussion/Interaction and moderator skills during presentations |
|
|
|
|
|
|
| Evaluation conditions (participation and/or pass) | ✔ |
|
| Conditions | Participation in assignments is compulsory |
|
|
|
| Consequences | You cannot be evaluated on your discussion/interaction skills or presentation/moderator skills during the assignment |
|
|
|
Second examination period
| Evaluation second examination opportunity different from first examination opprt | |
|
|
|
| Prerequisites |
| |
- The student should know the basic principles in pharmacology, toxicology, molecular genetics, cell pathology
- He/she is able to read scientific papers/course material in English
|
|
|
| Compulsory textbooks (bookshop) |
| |
[],[],[],[],[],[All lecture materials will be available on blackboard.] |
|
|
|
|
|
| first year Master of Biomedical Sciences - Clinical Biomedical Sciences | Compulsory | 108 | 4,0 | 108 | 4,0 | Yes | Yes | Numerical | |
|
| | | Learning outcomes |
- EC
| 1. A graduate of the Master of Biomedical Sciences has a thorough knowledge of the molecular and cellular processes of the healthy and diseased organism and has insight in different methods for prevention, diagnosis and therapy of diseases. | - EC
| 2. A graduate of the Master of Biomedical Sciences can independently and critically perform a literature search | - EC
| 4. A graduate of the Master of Biomedical Sciences has knowledge of state-of-the-art techniques within biomedical research and is able to apply these techniques, taking into account the applicable quality standards. | - EC
| 7. A graduate of the Master of Biomedical Sciences takes a critical attitude towards one's own research and that of others. | - EC
| 10. A graduate of the Master of Biomedical Sciences knows the potential for valorization of biomedical research and can translate own research into translational research. | - EC
| 12. A graduate of the Master of Biomedical Sciences has an attitude for lifelong learning and for constantly adjusting one's own professional thinking and acting. |
|
| | EC = learning outcomes DC = partial outcomes BC = evaluation criteria |
|
|
Course content:
- Introduction to “Drug delivery, Pharmacology, and Toxicology”
- PART 1: From basic to controlled drug delivery
- Pharmacokinetics of drugs
- Drug delivery systems: from basic to controlled
- Toxicity tests
- PART 2: Advanced drug delivery
- Targeting strategies and its clinical applications
- Barriers to overcome
- Toxicity of ‘new emerging compounds'
- PART 3: Preclinical Validation
- Preclinical validation using case studies
Learning goals:
- The student has insight in the pharmacokinetics of drugs
- The student can explain different drug delivery systems typically used for drug delivery, including controlled release
- The student can explain active and passive targeting drug delivery and has insight in its potential applications
- The student has insight in (particle) toxicity of drug delivery systems and how to take this into account in validation studies
- The student has insight in the trajectory of validation studies and can relate the interplay between research and clinical phases (MHD/KBW/Elective course)
|
|
|
|
|
|
|
|
|
Assignment ✔
|
|
|
|
Lecture ✔
|
|
|
|
|
|
|
|
Discussion/debate ✔
|
|
|
|
Group work ✔
|
|
|
|
Journal club ✔
|
|
|
|
Presentation ✔
|
|
|
|
Report ✔
|
|
|
|
Quarter 4 (4,00sp)
| Evaluation method | |
|
| Written evaluation during teaching period | 22 % |
|
| Transfer of partial marks within the academic year | ✔ |
|
|
|
|
|
|
|
| Oral evaluation during teaching period | 13 % |
|
| Transfer of partial marks within the academic year | ✔ |
|
|
|
|
| Other | Discussion/Interaction and moderator skills during presentations |
|
|
|
|
|
|
| Evaluation conditions (participation and/or pass) | ✔ |
|
| Conditions | Participation in assignments is compulsory |
|
|
|
| Consequences | You cannot be evaluated on your discussion/interaction skills or presentation/moderator skills during the assignment |
|
|
|
Second examination period
| Evaluation second examination opportunity different from first examination opprt | |
|
|
|
| Prerequisites |
| |
- The student should know the basic principles in pharmacology, toxicology, molecular genetics, cell pathology
- He/she is able to read scientific papers/course material in English
|
|
|
| Compulsory textbooks (bookshop) |
| |
[],[],[],[],[],[All lecture materials will be available on blackboard.] |
|
|
|
|
|
| 1st year Master of Biomedical Sciences - Bioelectronics and Nanotechnology | Optional | 108 | 4,0 | 108 | 4,0 | Yes | Yes | Numerical | |
|
| | | Learning outcomes |
- EC
| 1. A graduate of the Master of Biomedical Sciences has a thorough knowledge of the molecular and cellular processes of the healthy and diseased organism and has insight in different methods for prevention, diagnosis and therapy of diseases. | - EC
| 2. A graduate of the Master of Biomedical Sciences can independently and critically perform a literature search. | - EC
| 3. A graduate of the Master of Biomedical Sciences can draw up a new research hypothesis based on his or her own findings or based on the findings of others, and work out a research proposal for this. | - EC
| 4. A graduate of the Master of Biomedical Sciences has knowledge of state-of-the-art techniques within biomedical research and is able to apply these techniques, taking into account the applicable quality standards. | - EC
| 7. A graduate of the Master of Biomedical Sciences takes a critical attitude towards one's own research and that of others. | - EC
| 10. A graduate of the Master of Biomedical Sciences knows the potential for valorization of biomedical research and can translate own research into translational research. | - EC
| 12. A graduate of the Master of Biomedical Sciences has an attitude for lifelong learning and for constantly adjusting one's own professional thinking and acting. |
|
| | EC = learning outcomes DC = partial outcomes BC = evaluation criteria |
|
|
Course content:
- Introduction to “Drug delivery, Pharmacology, and Toxicology”
- PART 1: From basic to controlled drug delivery
- Pharmacokinetics of drugs
- Drug delivery systems: from basic to controlled
- Toxicity tests
- PART 2: Advanced drug delivery
- Targeting strategies and its clinical applications
- Barriers to overcome
- Toxicity of ‘new emerging compounds'
- PART 3: Preclinical Validation
- Preclinical validation using case studies
Learning goals:
- The student has insight in the pharmacokinetics of drugs
- The student can explain different drug delivery systems typically used for drug delivery, including controlled release
- The student can explain active and passive targeting drug delivery and has insight in its potential applications
- The student has insight in (particle) toxicity of drug delivery systems and how to take this into account in validation studies
- The student has insight in the trajectory of validation studies and can relate the interplay between research and clinical phases (MHD/KBW/Elective course)
|
|
|
|
|
|
|
|
|
Assignment ✔
|
|
|
|
Lecture ✔
|
|
|
|
|
|
|
|
Discussion/debate ✔
|
|
|
|
Group work ✔
|
|
|
|
Journal club ✔
|
|
|
|
Presentation ✔
|
|
|
|
Report ✔
|
|
|
|
Quarter 4 (4,00sp)
| Evaluation method | |
|
| Written evaluation during teaching period | 22 % |
|
| Transfer of partial marks within the academic year | ✔ |
|
|
|
|
|
|
|
| Oral evaluation during teaching period | 13 % |
|
| Transfer of partial marks within the academic year | ✔ |
|
|
|
|
| Other | Discussion/Interaction and moderator skills during presentations |
|
|
|
|
|
|
| Evaluation conditions (participation and/or pass) | ✔ |
|
| Conditions | Participation in assignments is compulsory |
|
|
|
| Consequences | You cannot be evaluated on your discussion/interaction skills or presentation/moderator skills during the assignment |
|
|
|
Second examination period
| Evaluation second examination opportunity different from first examination opprt | |
|
|
|
| Prerequisites |
| |
- The student should know the basic principles in pharmacology, toxicology, molecular genetics, cell pathology
- He/she is able to read scientific papers/course material in English
|
|
|
| Compulsory textbooks (bookshop) |
| |
[],[],[],[],[],[All lecture materials will be available on blackboard.] |
|
|
|
|
|
| Master of Teaching in Health Sciences keuzetraject BMW/GEN met vakdidactiek biologie | Optional | 108 | 4,0 | 108 | 4,0 | Yes | Yes | Numerical | |
| Master of Teaching in Health Sciences keuzetraject BMW/GEN met vakdidactiek chemie | Optional | 108 | 4,0 | 108 | 4,0 | Yes | Yes | Numerical | |
|
| | | Learning outcomes |
- EC
| The newly graduated student has insight into the construction and functioning of the diseased and healthy human body (at the molecular, cellular, organ and organism level). |
|
| | EC = learning outcomes DC = partial outcomes BC = evaluation criteria |
|
|
Course content:
- Introduction to “Drug delivery, Pharmacology, and Toxicology”
- PART 1: From basic to controlled drug delivery
- Pharmacokinetics of drugs
- Drug delivery systems: from basic to controlled
- Toxicity tests
- PART 2: Advanced drug delivery
- Targeting strategies and its clinical applications
- Barriers to overcome
- Toxicity of ‘new emerging compounds'
- PART 3: Preclinical Validation
- Preclinical validation using case studies
Learning goals:
- The student has insight in the pharmacokinetics of drugs
- The student can explain different drug delivery systems typically used for drug delivery, including controlled release
- The student can explain active and passive targeting drug delivery and has insight in its potential applications
- The student has insight in (particle) toxicity of drug delivery systems and how to take this into account in validation studies
- The student has insight in the trajectory of validation studies and can relate the interplay between research and clinical phases (MHD/KBW/Elective course)
|
|
|
|
|
|
|
|
|
Assignment ✔
|
|
|
|
Lecture ✔
|
|
|
|
|
|
|
|
Discussion/debate ✔
|
|
|
|
Group work ✔
|
|
|
|
Journal club ✔
|
|
|
|
Presentation ✔
|
|
|
|
Report ✔
|
|
|
|
Quarter 4 (4,00sp)
| Evaluation method | |
|
| Written evaluation during teaching period | 22 % |
|
| Transfer of partial marks within the academic year | ✔ |
|
|
|
|
|
|
|
| Oral evaluation during teaching period | 13 % |
|
| Transfer of partial marks within the academic year | ✔ |
|
|
|
|
| Other | Discussion/Interaction and moderator skills during presentations |
|
|
|
|
|
|
| Evaluation conditions (participation and/or pass) | ✔ |
|
| Conditions | Participation in assignments is compulsory |
|
|
|
| Consequences | You cannot be evaluated on your discussion/interaction skills or presentation/moderator skills during the assignment |
|
|
|
Second examination period
| Evaluation second examination opportunity different from first examination opprt | |
|
|
|
| Prerequisites |
| |
- The student should know the basic principles in pharmacology, toxicology, molecular genetics, cell pathology
- He/she is able to read scientific papers/course material in English
|
|
|
| Compulsory textbooks (bookshop) |
| |
[],[],[],[],[],[All lecture materials will be available on blackboard.] |
|
|
|
|
|
1 examination regulations art.1.3, section 4. |
| 2 examination regulations art.4.7, section 2. |
3 examination regulations art.2.2, section 3.
|
| Legend |
| SBU : course load | SP : ECTS | N : Dutch | E : English |
|